Targeting CDK9 with Wogonin as a therapeutic strategy for chronic myeloid leukemia Research Square 1:52 3 years ago 187 Скачать Далее
The need to identify new treatment strategies in CMML & the potential of targeting inflammation VJHemOnc – Video Journal of Hematology & HemOnc 2:03 1 year ago 477 Скачать Далее
CDK9 Inhibitors: Promising Combination Partner for Hematological Malignancy Treatment | Oncotarget Oncotarget 1:19 1 year ago 71 Скачать Далее
CDK9 inhibition with voruciclib for treating AML and R/R B-cell NHL VJHemOnc – Video Journal of Hematology & HemOnc 2:15 8 months ago 93 Скачать Далее
Understanding the Functions of CDC7 and CDK1 in Cell Division Cycles Smolecule Inc. 1:00 2 years ago 72 Скачать Далее
Molecules in VR: Investigating Cyclin-Dependent Kinase Selectivity Nanome 16:13 2 years ago 472 Скачать Далее
Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C in Hyperlipidemia and ASCVD PeerView CME 1:37:52 3 years ago 377 Скачать Далее
Chronic Myelogenous Leukemia . Medical Education Podcast White Coat Hackers 12:03 3 years ago 33 Скачать Далее
Vincerx presents 2021 ASH data on CDK9/PTEFb inhibitor VIP152 on Phase 1 clinical trial. Vincerx Pharma 4:58 2 years ago 376 Скачать Далее
Management strategies for acute and chronic GvHD following alloSCT VJHemOnc – Video Journal of Hematology & HemOnc 0:58 6 months ago 69 Скачать Далее
The potential clinical significance of CDK6 inhibitors in leukemia VJHemOnc – Video Journal of Hematology & HemOnc 1:32 8 years ago 177 Скачать Далее
Selecting a Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia Case Study OncLive 9:08 8 years ago 930 Скачать Далее
Feasibility of sequential treatment with CD19-targeted agents in patients with LBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:26 1 year ago 115 Скачать Далее
Investigating mechanisms of resistance to CDK4/6 inhibitors VJOncology 0:50 1 year ago 157 Скачать Далее
Cyclacel Pharmaceuticals – Cell Cycle Inhibitor Study in Solid and Blood Cancers HPR 10:26 1 year ago 102 Скачать Далее
